KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Repurchased
Ratios

Medpace Holdings (MEDP) EBIAT (2016 - 2025)

Historic EBIAT for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $111.1 million.

  • Medpace Holdings' EBIAT rose 1525.42% to $111.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $433.0 million, marking a year-over-year increase of 1841.63%. This contributed to the annual value of $404.4 million for FY2024, which is 4298.86% up from last year.
  • As of Q3 2025, Medpace Holdings' EBIAT stood at $111.1 million, which was up 1525.42% from $90.3 million recorded in Q2 2025.
  • Medpace Holdings' 5-year EBIAT high stood at $117.0 million for Q4 2024, and its period low was $39.9 million during Q2 2021.
  • Its 5-year average for EBIAT is $75.3 million, with a median of $70.6 million in 2023.
  • Within the past 5 years, the most significant YoY rise in Medpace Holdings' EBIAT was 6567.37% (2021), while the steepest drop was 163.57% (2021).
  • Over the past 5 years, Medpace Holdings' EBIAT (Quarter) stood at $50.0 million in 2021, then skyrocketed by 37.25% to $68.7 million in 2022, then rose by 14.02% to $78.3 million in 2023, then surged by 49.45% to $117.0 million in 2024, then decreased by 5.03% to $111.1 million in 2025.
  • Its EBIAT was $111.1 million in Q3 2025, compared to $90.3 million in Q2 2025 and $114.6 million in Q1 2025.